TRANSMEDICS GROUP INC (TMDX)
US89377M1099 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to TMDX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 101.39. This target is 13.6% above the current price.
TMDX was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about TMDX.
In the previous month the buy percentage consensus was at a similar level.
TMDX was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-28 | Piper Sandler | Initiate | Overweight |
| 2024-02-28 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-27 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-02-27 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-12-04 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-07 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-11-07 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-10-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-04 | TD Cowen | Maintains | Outperform -> Outperform |
| 2023-07-19 | William Blair | Initiate | Outperform |
| 2023-05-18 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-05-03 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-05-02 | Oppenheimer | Maintains | Outperform |
| 2023-02-23 | Oppenheimer | Maintains | Outperform |
| 2023-02-23 | Cowen & Co. | Maintains | Outperform |
| 2023-02-23 | JP Morgan | Maintains | Overweight |
| 2023-02-23 | Canaccord Genuity | Maintains | Buy |
| 2023-02-23 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-01-06 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-11-04 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-10-11 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-08-03 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-08-02 | Oppenheimer | Maintains | Outperform |
| 2022-08-02 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2022-07-26 | Cowen & Co. | Maintains | Outperform |
| 2022-06-29 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-06-28 | Cowen & Co. | Maintains | Outperform |
| 2022-05-04 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-02-25 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-01-07 | Morgan Stanley | Maintains | Equal-Weight |